Zydus Lifesciences is innovating a single-device for semaglutide. This device can deliver multiple strengths of the drug. It ...

It's been a challenging year for NovoCure (NASDAQ: NVCR), an oncology-focused biotech. NovoCure's average price target on ...

The FDA approved Abbott's Tendyne minimally invasive heart replacement for mitral valve disease that could disqualify ...

Uttar Pradesh's pharma sector attracted ₹2,845 crore investment, creating 70,000+ jobs in three years, aided by the Nivesh ...

The North Carolina Biotechnology Center’s newly relaunched Career Center site is now fully automated. On one recent day, the site listed nearly 2,000 jobs – about 15 times more jobs than the previous ...

Orchestra BioMed holds two best-in-class medical device therapies targeting large markets. Find out why OBIO stock is a Buy.

Kathe D'Alfonso is an inventor, entrepreneur, owner of Solo Beauty, and the mind behind this device. READ MORE, <a href=" ...

Auxilium’s pivotal trial aims to enrol 80 patients who will receive its NeuroSpan Bridge device for nerve regeneration or a ...

From mRNA breakthroughs to cloud-based analytics, sector specialists outline the technological innovations and skills ...

PL logistics need to invest in new technology and upskilling programs to scale their cell and gene therapy services.

1. Data protection periods of 6 years, 3 years and 3 years are set for innovative drugs, improved new drugs and first generic ...

In the race to decarbonize the global economy, advanced materials are no longer a luxury – they’re a necessity.